Can axillary node clearance (ANC) be avoided in selected clinically node positive breast cancers (cN+BC) after neoadjuvant therapy (NAT)?

Ms Ilaria Giona
15.05.2017

ABS Conference 2017

Added: 15.05.2017
Play play_circle

Classifications: Breast & Oncoplastic Surgery

Keywords: Axilla Neoadjuvant Chemotherapy/ NACT